CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Andere Sprachen Charles River Laboratories International, Inc. Xetra

Aktien

939391

US1598641074

RV6

Verzögert Xetra Andere Börsenplätze 17:35:34 10.08.2022			% 5 Tage	% 1. Jan.
215,8 ^EUR	-2,40 %		-.--%	-.--%

13.06.	CHARLES RIVER LABORATORIES INTERNATIONAL, INC. : Baird bekräftigt seine Kaufempfehlung	ZM
07.06.	CHARLES RIVER LABORATORIES INTERNATIONAL, INC. : Mizuho Securities ist jetzt neutral	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives	11.06.
The job report just threw a spanner in the works	07.06.
RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK : Lyft, Amazon, Fedex, Xpo, Vail Resorts, Unilever...	07.06.
Charles River Laboratories Expands Access to CRADL Contract Vivarium Space in Somerville	07.06.
ANALYST RECOMMENDATIONS : Lyft, Amazon, Fedex, Xpo, Unilever...	07.06.
Charles River Laboratories Opens New Contract Vivarium Space in Massachusetts	06.06.
The first rate cut	06.06.
RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK : American Airlines, Salesforce, Five Below, Tesla, Okta...	06.06.
Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville	06.06.
Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville	06.06.
ANALYST RECOMMENDATIONS : American Airlines, Salesforce, Five Below, Tesla, Okta...	06.06.
Charles River Laboratories, Sanofi Collaborating to Develop Non-Animal Virtual Control Groups for Preclinical Trials	04.06.
Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research	04.06.
Charles River Laboratories to Present at William Blair and Jefferies Conferences	03.06.
Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development	30.05.
Charles River Laboratories International, Inc. Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development	30.05.
Declaration of Voting Results of Charles River Laboratories International Inc	10.05.
Charles River Laboratories International Q1 Non-GAAP Earnings Rise, Revenue Fall; Maintains Full Year 2024 Earnings Guidance	09.05.
Charles River Laboratories International, Inc. Reports Impairment Charges for the First Quarter Ended March 30, 2024	09.05.
Charles River Laboratories International, Inc. Reports Earnings Results for the First Quarter Ended March 30, 2024	09.05.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Charles River Laboratories International, Inc. Xetra

Aktien

939391

US1598641074

RV6

Andere Sprachen

Filter